Skip to main content
SpringerLink
Log in

Darifenacin

A Viewpoint by Francois Haab

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Author information

Authors and Affiliations

  1. Département d’Urologie, Hôpital Tenon, Paris, France

    Francois Haab

Authors
  1. Francois Haab
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haab, F. Darifenacin. Drugs Aging 21, 893 (2004). https://doi.org/10.2165/00002512-200421130-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200421130-00007

Keywords

Search

Navigation